This data confirms that semaglutide stands apart as the only available GLP-1-based medication with proven cardiovascular benefits for people living with obesity and cardiovascular disease, without diabetes," Ludovic Helfgott, Novo Nordisks head of product and portfolio strategy, said in a news release
Both medications are typically administered as once-weekly injections, providing convenience and ease for our patients
Taking your tirzepatide injection 24 hours early is generally considered safe and does not pose an immediate medical risk in most cases
Consequently, patients can see more significant weight loss results
High-quality protein sources include lean poultry, fish, eggs, Greek yogurt, cottage cheese, and legumes